Summer 2023 Recap: Here’s What You Missed From MAI

Article

Summer 2023 Recap: Here’s What You Missed From MAI

September 13, 2023
Authors
Topics

Welcome to the September 2023 edition of our Monthly Insight Series. This month we are giving a quick overview of the various reports we’ve released to our clients this summer—it’s been a busy one!

Businessman in suit pointing to digital illustration of business icons.

Our team has been hard at work parsing out the most important trends and generating meaningful insights across our customer segments for your company’s business needs. Here’s a quick overview of all of the reports and insights we’ve released this summer, which you can dive into here after signing into our client portal.

Integrated Delivery Networks

  • IDN Oncology Annual Trend Report: Studies IDNs’ matrix structures, operational scales, and differing stakeholder needs and incentives in an effort to discern patterns that can inform improved engagement with these evolving and complex networks. 
  • IDN Dataset & User Guide: Features individual IDN–level information from the latest IDN oncology research, including a functional road map for account data, brand-specific information, and a new trend comparison tool.  
  • IDN Brand Planning Insights Summary: Consolidates the most salient takeaway points from our latest IDN oncology research to help your teams build out sections of your annual brand/strategic plans. 

Community Oncology

  • Community Oncology Annual Trend Report: Takes a deep dive into the most important trends occurring in community practices to help your teams understand practices with markedly different business models that require different engagement strategies.
  • Community Brand Planning Insights Summary: Consolidates the most salient takeaway points from our latest community oncology research to help your teams build out sections of your annual brand/strategic plans.

Payers

  • Payer Brand Planning Insights Summary: Consolidates and updates the most salient takeaway points from our 2022 payer research to help your teams build out sections of your annual brand/strategic plans.

Cross-Segment Reports

  • Landscape Report – Part One: Investigates the rising market concentration among health plans, especially in Medicare Advantage; the continued expansion of IDNs’ own physician networks; and the “paper gulag” that accompanies these expansions.

Coming in September and October

  • Community Oncology Practice Directory
  • Payer Annual Trend Report
  • Pathways Report – Part One
  • Landscape Report – Part Two

For further insights and musings on the oncology sector, please also check out our latest articles at https://www.hmpmarketaccessinsights.com/insights. From articles on the Enhancing Oncology Model and IDN pharmacy performance metrics to payer pathways, we are sure to cover a topic that piques your interest! 

The Latest

Easier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage.
Article
Easier Pathway Access, Greater Pathway Usage

Easier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage.

Cindy Chen
Our 2024-2025 Oncology Clinical Pathways Report, set for release in December, will provide insights into the most impactful pathways and key factors manufacturers should assess as the oncology pathways landscape continues to evolve.
Article
Unlocking Oncology Pathway Impact: Beyond Lives Covered to Real Prescribing Influence

As Oncology pathway programs continue to become more prominent in the marketplace, manufacturers are being challenged to assess how influential a specific pathway is.

Daniel Buchenberger
Podcast
Community Oncology Practice Economics - Podcast Part 3 of 3

In the final part of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore emerging models for success in oncology practice economics.

Lee Blansett